Widex families on future WSA co-owners: Danish investors preferred to public listing

The families behind one half of the merger company WSA dream of bringing in ”bigger, long-term Danish investors” as an alternative to an initial public offering once equity firm and co-owner EQT exits the investment.

Lars Nørgaard, CEO of T&W Medical, the holding company of the Widex founding families, Tøpholm and Westermann | Photo: Gregers Tycho

When equity firm EQT exits hearing aid giant WS Audiology at some point in the future, going public could be the obvious option.

However, the founding families Tøpholm and Westermann, who own 51 percent of the company, would rather see the equity firm’s share go to ”long-term Danish investors.”

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs